Name: Can-Fite BioPharma
Address: 10 Bareket Street, Petah-Tikva, 49170, ISRAEL
Telephone: +972-3-9241114

Filing Type:

Year:

Date	Form	Description	Pages
11/14/24	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	7
11/12/24	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	2
11/04/24	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	3
10/18/24	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	3
10/09/24	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	2
09/24/24	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	3
09/16/24	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	2
09/06/24	CORRESP	A correspondence can be sent as a document with another submission type or can be sent as a separate submission.	1
09/06/24	EFFECT	Notice of Effectiveness	1
09/06/24	424B3	Prospectus filed pursuant to Rule 424(b)(3)	20